Voyager Therapeutics, Inc.
VYGR· Nasdaq
Voyager Therapeutics, Inc.
- Last sale
- Oct 2, 2026 · -8.99%
- Market cap
- $149.73M
- 61.62M shares
- Filings
- 678
Price
Oct 2, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $40,374,000 | reported | |
| FY 2024 | 2024-12-31 | $80,001,000 | reported | |
| FY 2023 | 2023-12-31 | $250,008,000 revised | reported | |
| FY 2022 | 2022-12-31 | $40,907,000 | reported | |
| FY 2021 | 2021-12-31 | $37,415,000 | reported | |
| FY 2020 | 2020-12-31 | $171,128,000 | reported | |
| FY 2019 | 2019-12-31 | $104,391,000 | reported | |
| FY 2018 | 2018-12-31 | $7,619,000 | reported | |
| FY 2017 | 2017-12-31 | $10,135,000 | reported | |
| FY 2016 | 2016-12-31 | $14,220,000 | reported | |
| FY 2015 | 2015-12-31 | $17,334,000 | reported |
Voyager Therapeutics, Inc. · CIK 1640266 · Engraved from SEC EDGAR
